
- /
- Supported exchanges
- / TO
Medicenna Therapeutics Corp (MDNA TO) stock market data APIs
Medicenna Therapeutics Corp Financial Data Overview
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops bizaxofusp (MDNA55), an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a masked bi-functional anti-PD1-IL2 Superkine for various solid tumors; and MDNA132, an IL-13 Superkine for various tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, inhibitors, antibodies, cytokines, or other Superkines Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Medicenna Therapeutics Corp data using free add-ons & libraries
Get Medicenna Therapeutics Corp Fundamental Data
Medicenna Therapeutics Corp Fundamental data includes:
- Net Revenue: 0
- EBITDA: -18 247 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-02-12
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Medicenna Therapeutics Corp News

3 TSX Growth Companies With High Insider Ownership Growing Revenues At 10%
In the wake of a decisive U.S. election outcome, Canadian markets have been influenced by the potential policy shifts south of the border, with fundamental conditions remaining favorable for growth. A...


3 TSX Growth Companies With High Insider Ownership And 12% Revenue Growth
In the wake of a decisive U.S. election outcome, the Canadian market has seen renewed optimism, with the TSX reaching multiple record highs this year as investors anticipate potential policy shifts. I...

3 TSX Growth Companies With Strong Insider Ownership
In the current Canadian market landscape, investors are navigating a complex environment influenced by shifting expectations around interest rate policies and productivity trends, particularly in ligh...

Top TSX Growth Companies With High Insider Ownership October 2024
The Canadian market has shown robust performance, with a 1.4% increase over the last week and a significant 28% climb in the past year, alongside expectations for earnings growth of 16% per annum in t...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.